What Next?

Well it’s Friday and before we hit the weekend and do another triathlon it’s time to speculate a little. Will Abbott do something to keep the Libre in the CGM game? Will Apple do more than just partner with diabetes device companies? Will Google be content to be Dexcom’s partner or will they pull the trigger and buy the company?

While they would never admit it publicly we have a feeling our friends in Northridge are looking at alternate options in CGM. This doesn’t mean they won’t make enhancements to the Guardian Connect rather increase . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.